Concepedia

Louis Rebaud

LR

4

Publications

127

Citations

4

H-Index

2022

Active since

Affiliations

Assistance Publique – Hôpitaux de Paris(Current)

Inserm

Hôpital Cochin

Institut Curie

Université Paris Cité

Louis Rebaud is an author at Assistance Publique – Hôpitaux de Paris specializing in cancer research, oncology, and medicine.

ORCID

Top concepts

Publications per year

2022–2023

4

Publications

4

<sup>18</sup>F-FDG PET Maximum-Intensity Projections and Artificial Intelligence: A Win-Win Combination to Easily Measure Prognostic Biomarkers in DLBCL Patients

Kibrom Berihu Girum, Louis Rebaud, Anne‐Ségolène Cottereau et al. · Journal of Nuclear Medicine · 2022 · 54 citations · Full text

Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine‐treated, interimPET‐negative classical Hodgkin Lymphoma patients: A radio‐genomic study

Rexhep Durmo, Benedetta Donati, Louis Rebaud et al. · Hematological Oncology · 2022 · 32 citations · Full text

, , +16

Metabolic tumor volume predicts outcome in patients with advanced stage follicular lymphoma from the RELEVANCE trial

Anne‐Ségolène Cottereau, Louis Rebaud, Judith Trotman et al. · Annals of Oncology · 2023 · 29 citations · Full text

, , +7

Tumor Location Relative to the Spleen Is a Prognostic Factor in Lymphoma Patients: A Demonstration from the REMARC Trial

Kibrom Berihu Girum, Anne‐Ségolène Cottereau, Laëtitia Vercellino et al. · Journal of Nuclear Medicine · 2023 · 12 citations · Full text

Rows per page

1–4 of 4